Terms: = Germ cell tumor AND CDK6, MGC59692, 1021, Q00534, ENSG00000105810, PLSTIRE AND Prognosis
48 results:
1. Comprehensive molecular findings in primary malignant melanoma of the esophagus: A multicenter study.
Deng L; Wang HY; Hu CF; Liu XY; Jiang K; Yong JJ; Wu XY; Guo KH; Wang F
Pigment Cell Melanoma Res; 2024 May; 37(3):363-371. PubMed ID: 38158377
[TBL] [Abstract] [Full Text] [Related]
2. Novel insight into histological and molecular astrocytoma, IDH-mutant, Grade 4 by the updated WHO classification of central nervous system tumors.
Chen W; Guo S; Wang Y; Shi Y; Guo X; Liu D; Li Y; Wang Y; Xing H; Xia Y; Li J; Wu J; Liang T; Wang H; Liu Q; Jin S; Qu T; Li H; Yang T; Zhang K; Wang Y; Ma W
Cancer Med; 2023 Sep; 12(18):18666-18678. PubMed ID: 37667984
[TBL] [Abstract] [Full Text] [Related]
3. Development and validation of a glioma-associated mesenchymal stem cell-related gene prognostic index for predicting prognosis and guiding individualized therapy in glioma.
Peng Z; Wu Y; Wang J; Gu S; Wang Y; Xue B; Fu P; Xiang W
Stem Cell Res Ther; 2023 Apr; 14(1):56. PubMed ID: 37005685
[TBL] [Abstract] [Full Text] [Related]
4. Pharmacological inhibition of EZH2 by ZLD1039 suppresses tumor growth and pulmonary metastasis in melanoma cells in vitro and in vivo.
Zhu Y; Zhang L; Song X; Zhang Q; Wang T; Xiao H; Yu L
Biochem Pharmacol; 2023 Apr; 210():115493. PubMed ID: 36898415
[TBL] [Abstract] [Full Text] [Related]
5. Genomic profiling and prognostic factors of H3 K27M-mutant spinal cord diffuse glioma.
Chai RC; Yan H; An SY; Pang B; Chen HY; Mu QH; Zhang KN; Zhang YW; Liu YQ; Liu X; Zhao Z; Jiang T; Wang YZ; Jia WQ
Brain Pathol; 2023 Jul; 33(4):e13153. PubMed ID: 36751054
[TBL] [Abstract] [Full Text] [Related]
6. IKBIP, a novel glioblastoma biomarker, maintains abnormal proliferation of tumor cells by inhibiting the ubiquitination and degradation of CDK4.
Li K; Huang G; Wang Z; Yang R; Zhang W; Ni B; Guan J; Yi G; Li Z; Zhu Q; Peng Q; Yang L; Qi L; Liu Y
Biochim Biophys Acta Mol Basis Dis; 2023 Jan; 1869(1):166571. PubMed ID: 36244542
[TBL] [Abstract] [Full Text] [Related]
7. Genetic Markers as Predictors for Response to Treatment and Possible Therapeutic Targets in Medulloblastoma.
Pérez-Pineda PL; Ortiz-Butrón R; Pérez-De Marcos JC; Hernández-Regino LM; Zapata-Tarrés MM; Torres-Espíndola LM
CNS Neurol Disord Drug Targets; 2023; 22(5):634-642. PubMed ID: 35579144
[TBL] [Abstract] [Full Text] [Related]
8. Syringic Acid Suppressed Proliferation, Invasion, and Migration via Inhibition of Matrix Metalloproteinases Expression on Glioblastoma cells by Promoting Apoptosis.
Li D; Luo D; Hu S; Zhao H; Peng B
Curr Pharm Biotechnol; 2023; 24(2):310-316. PubMed ID: 35570553
[TBL] [Abstract] [Full Text] [Related]
9. High Expression of the Lysosomal Protease Cathepsin D Confers Better prognosis in Neuroblastoma Patients by Contrasting EGF-Induced Neuroblastoma cell Growth.
Secomandi E; Salwa A; Vidoni C; Ferraresi A; Follo C; Isidoro C
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563171
[TBL] [Abstract] [Full Text] [Related]
10. Molecular Stratification of Medulloblastoma: Clinical Outcomes and Therapeutic Interventions.
Sursal T; Ronecker JS; Dicpinigaitis AJ; Mohan AL; Tobias ME; Gandhi CD; Jhanwar-Uniyal M
Anticancer Res; 2022 May; 42(5):2225-2239. PubMed ID: 35489737
[TBL] [Abstract] [Full Text] [Related]
11. Severe blistering eruptions induced by immune checkpoint inhibitors: a multicentre international study of 32 cases.
Ingen-Housz-Oro S; Milpied B; Badrignans M; Carrera C; Elshot YS; Bensaid B; Segura S; Apalla Z; Markova A; Staumont-Sallé D; Marti-Marti I; Giavedoni P; Chua SL; Darrigade AS; Dezoteux F; Starace M; Torre AC; Riganti J; de Prost N; Lebrun-Vignes B; Bauvin O; Walsh S; Ortonne N; French LE; Sibaud V
Melanoma Res; 2022 Jun; 32(3):205-210. PubMed ID: 35377864
[TBL] [Abstract] [Full Text] [Related]
12. The RNA-Binding Protein Musashi1 Regulates a Network of cell Cycle Genes in Group 4 Medulloblastoma.
Baroni M; Guardia GDA; Lei X; Kosti A; Qiao M; Landry T; Mau K; Galante PAF; Penalva LOF
Cells; 2021 Dec; 11(1):. PubMed ID: 35011618
[TBL] [Abstract] [Full Text] [Related]
13. ZC3H15 Correlates with a Poor prognosis and tumor Progression in Melanoma.
Li Q; Hou J; Guo C; Zhang Y; Liu L; Hu H; Shi S; Ji Y; Guo L; Shi Y; Liu Y; Cui H
Biomed Res Int; 2021; 2021():8305299. PubMed ID: 34988227
[TBL] [Abstract] [Full Text] [Related]
14. NAP1L1 promotes proliferation and chemoresistance in glioma by inducing CCND1/CDK4/cdk6 expression through its interaction with HDGF and activation of c-Jun.
Chen Z; Xie Y; Luo H; Song Y; Que T; Hu R; Huang H; Luo K; Li C; Qin C; Zheng C; Fang W; Liu L; Long H; Luo Q
Aging (Albany NY); 2021 Dec; 13(24):26180-26200. PubMed ID: 34959221
[TBL] [Abstract] [Full Text] [Related]
15. CDK4/6 Inhibitors in Melanoma: A Comprehensive Review.
Garutti M; Targato G; Buriolla S; Palmero L; Minisini AM; Puglisi F
Cells; 2021 May; 10(6):. PubMed ID: 34071228
[TBL] [Abstract] [Full Text] [Related]
16. GSG2 knockdown suppresses cholangiocarcinoma progression by regulating cell proliferation, apoptosis and migration.
Zhou J; Nie W; Yuan J; Zhang Z; Mi L; Wang C; Huang R
Oncol Rep; 2021 Jun; 45(6):. PubMed ID: 33846801
[TBL] [Abstract] [Full Text] [Related]
17. LncRNA PCGEM1 contributes to malignant behaviors of glioma by regulating miR-539-5p/cdk6 axis.
Liu SL; Chen MH; Wang XB; You RK; An XW; Zhao Q; Wang RS
Aging (Albany NY); 2021 Feb; 13(4):5475-5484. PubMed ID: 33589577
[TBL] [Abstract] [Full Text] [Related]
18. miR-149 rs2292832 C allele enhances the cytotoxic effect of temozolomide against glioma cells.
Xu B; Luo X; Ning X; Luo J; Guo J; Liu Q; Ling G
Neuroreport; 2020 Apr; 31(6):498-506. PubMed ID: 32243354
[TBL] [Abstract] [Full Text] [Related]
19. MiR-1253 exerts tumor-suppressive effects in medulloblastoma via inhibition of cdk6 and CD276 (B7-H3).
Kanchan RK; Perumal N; Atri P; Chirravuri Venkata R; Thapa I; Klinkebiel DL; Donson AM; Perry D; Punsoni M; Talmon GA; Coulter DW; Boue' DR; Snuderl M; Nasser MW; Batra SK; Vibhakar R; Mahapatra S
Brain Pathol; 2020 Jul; 30(4):732-745. PubMed ID: 32145124
[TBL] [Abstract] [Full Text] [Related]
20. Presenilin1 exerts antiproliferative effects by repressing the Wnt/β-catenin pathway in glioblastoma.
Yang W; Wu PF; Ma JX; Liao MJ; Xu LS; Xu MH; Yi L
Cell Commun Signal; 2020 Feb; 18(1):22. PubMed ID: 32046730
[TBL] [Abstract] [Full Text] [Related]
[Next]
